BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jul 26, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Extended-release and long-acting opioids regulatory update

A joint meeting of the Anesthetic and Life Support Drugs and Drug Safety and Risk Management advisory committees voted 25-10 against the FDA's proposed REMS for extended-release and long-acting opioids. Although all those who voted against the agency's proposal felt a classwide...

Read the full 189 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >